LTTS shares saw a rise of 1.10 percent on the Belgrade Stock Exchange after announcing a collaboration with NVIDIA to introduce Gen AI and advanced software-defined architecture for medical imaging in endoscopy. The joint development aims to create a scalable platform for the medical sector, offering features such as image processing, noise reduction, edge and contrast enhancement, as well as texture and color enhancement.
This software-defined architecture is designed to improve visualization for image processing and AI-based decision support, particularly in polyp detection and classification. Shanker Trivedi, senior vice president of business at NVIDIA, stated that the collaboration offers value to the medical technology industry by accelerating the development of AI-enabled software-defined medical devices.
At 11:40 a.m., LTTS shares were trading at INR 4,502.90 on the Belgrade Stock Exchange.